日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Combined pembrolizumab and bevacizumab therapy effectively inhibits non-small-cell lung cancer growth and prevents postoperative recurrence and metastasis in humanized mouse model

派姆单抗与贝伐单抗联合治疗在人源化小鼠模型中有效抑制非小细胞肺癌生长并预防术后复发和转移

Tianyun Qiao #, Jinbo Zhao #, Xiangbing Xin #, Yanlu Xiong, Wenwen Guo, Fancheng Meng, Hui Li, Yangbo Feng, Hui Xu, Changhong Shi, Yong Han

TFAP2A potentiates lung adenocarcinoma metastasis by a novel miR-16 family/TFAP2A/PSG9/TGF-β signaling pathway

TFAP2A通过一种新型的miR-16家族/TFAP2A/PSG9/TGF-β信号通路增强肺腺癌转移

Yanlu Xiong,Yangbo Feng,Jinbo Zhao,Jie Lei,Tianyun Qiao,Yongsheng Zhou,Qiang Lu,Tao Jiang,Lintao Jia,Yong Han

The novel BET inhibitor UM-002 reduces glioblastoma cell proliferation and invasion

新型 BET 抑制剂 UM-002 可降低胶质母细胞瘤细胞增殖和侵袭

Anna M Jermakowicz #, Matthew J Rybin #, Robert K Suter #, Jann N Sarkaria, Zane Zeier, Yangbo Feng, Nagi G Ayad

Inhibition of LDH-A by Oxamate Enhances the Efficacy of Anti-PD-1 Treatment in an NSCLC Humanized Mouse Model

草氨酸抑制LDH-A可增强NSCLC人源化小鼠模型中抗PD-1治疗的疗效

Tianyun Qiao, Yanlu Xiong, Yangbo Feng, Wenwen Guo, Yongsheng Zhou, Jinbo Zhao, Tao Jiang, Changhong Shi, Yong Han

A New Quantitative Cell-Based Assay Reveals Unexpected Microtubule Stabilizing Activity of Certain Kinase Inhibitors, Clinically Approved or in the Process of Approval

一种新的定量细胞测定方法揭示了某些激酶抑制剂的意外微管稳定活性,这些抑制剂已获得临床批准或正在审批中

Sacnicte Ramirez-Rios, Sophie Michallet, Leticia Peris, Caroline Barette, Clotilde Rabat, Yangbo Feng, Marie-Odile Fauvarque, Annie Andrieux, Karin Sadoul, Laurence Lafanechère

Computer-aided discovery of phenylpyrazole based amides as potent S6K1 inhibitors

计算机辅助发现苯基吡唑类酰胺作为有效的 S6K1 抑制剂

Yan Yin, Yuxing Sun, Lianhua Zhao, Jinpeng Pan, Yangbo Feng

Superselective Renal Artery Embolization Management of Post-percutaneous Nephrolithotomy Hemorrhage and Its Methods

超选择性肾动脉栓塞治疗经皮肾镜取石术后出血及其方法

Dong, Xiangjun; Ren, Yanqiao; Han, Ping; Chen, Lei; Sun, Tao; Su, Yangbo; Feng, Yiming; Ma, Jinqiang; Liang, Huimin; Zheng, Chuansheng

Rho Kinase Inhibition as a Therapeutic for Progressive Supranuclear Palsy and Corticobasal Degeneration

Rho 激酶抑制剂作为进行性核上性麻痹和皮层基底节变性的治疗方法

Erik G Gentry, Benjamin W Henderson, Andrew E Arrant, Marla Gearing, Yangbo Feng, Nicole C Riddle, Jeremy H Herskowitz

Bis-aryl urea derivatives as potent and selective LIM kinase (Limk) inhibitors

双芳基脲衍生物作为强效和选择性 LIM 激酶 (Limk) 抑制剂

Yan Yin, Ke Zheng, Nibal Eid, Shannon Howard, Ji-Hak Jeong, Fei Yi, Jia Guo, Chul Min Park, Mathieu Bibian, Weilin Wu, Pamela Hernandez, HaJeung Park, Yuntao Wu, Jun-Li Luo, Philip V LoGrasso, Yangbo Feng

Design and synthesis of highly potent and isoform selective JNK3 inhibitors: SAR studies on aminopyrazole derivatives

高效异构体选择性 JNK3 抑制剂的设计和合成:氨基吡唑衍生物的 SAR 研究

Ke Zheng, Sarah Iqbal, Pamela Hernandez, HaJeung Park, Philip V LoGrasso, Yangbo Feng